tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

VIGL Stock Latest News

Vigil Neuroscience Inc.: Promising Biomarker Data and Strategic Advancements Justify Buy Rating
RatingsVigil Neuroscience Inc.: Promising Biomarker Data and Strategic Advancements Justify Buy Rating
14d ago
VIGL
Vigil Neuroscience price target lowered to $14 from $17 at H.C. Wainwright
PremiumThe Fly
Vigil Neuroscience price target lowered to $14 from $17 at H.C. Wainwright
14d ago
VIGL
Vigil Neuroscience price target lowered to $13 from $24 at Wedbush
PremiumThe Fly
Vigil Neuroscience price target lowered to $13 from $24 at Wedbush
14d ago
VIGL
Vigil Neuroscience Faces Market Risks from Preferred Stock Issuance and Potential Share Dilution
PremiumCompany Announcements
Vigil Neuroscience Faces Market Risks from Preferred Stock Issuance and Potential Share Dilution
14d ago
VIGL
Promising Clinical Progress and Strategic Advancements Justify Buy Rating for Vigil Neuroscience
PremiumRatings
Promising Clinical Progress and Strategic Advancements Justify Buy Rating for Vigil Neuroscience
15d ago
VIGL
Promising Clinical Progress and Strong Financial Position Support Buy Rating for Vigil Neuroscience
PremiumRatingsPromising Clinical Progress and Strong Financial Position Support Buy Rating for Vigil Neuroscience
15d ago
VIGL
Vigil Neuroscience reports Q4 EPS (57c), consensus (47c)
Premium
The Fly
Vigil Neuroscience reports Q4 EPS (57c), consensus (47c)
15d ago
VIGL
Vigil Neuroscience sees cash runway into 2026
Premium
The Fly
Vigil Neuroscience sees cash runway into 2026
15d ago
VIGL
Vigil likely to land Alzheimer’s deal after today’s data, says Mizuho
PremiumThe Fly
Vigil likely to land Alzheimer’s deal after today’s data, says Mizuho
2M ago
VIGL
Vigil Neuroscience Announces Positive Phase 1 Trial Results
PremiumCompany Announcements
Vigil Neuroscience Announces Positive Phase 1 Trial Results
2M ago
8K
VIGL
Vigil Neuroscience reports data from Phase 1 trial on VG-3927
PremiumThe Fly
Vigil Neuroscience reports data from Phase 1 trial on VG-3927
2M ago
VIGL
Vigil Neuroscience initiated with an Outperform at William Blair
PremiumThe Fly
Vigil Neuroscience initiated with an Outperform at William Blair
4M ago
VIGL
Vigil Neuroscience initiated with an Outperform at William Blair
PremiumThe FlyVigil Neuroscience initiated with an Outperform at William Blair
4M ago
VIGL
Vigil Neuroscience Advances Key Clinical Programs
Premium
Company Announcements
Vigil Neuroscience Advances Key Clinical Programs
5M ago
VIGL
Vigil Neuroscience reports Q3 EPS (47c), consensus (54c)
Premium
The Fly
Vigil Neuroscience reports Q3 EPS (47c), consensus (54c)
5M ago
VIGL
Vigil Neuroscience story ‘gaining momentum,’ says Jefferies
PremiumThe Fly
Vigil Neuroscience story ‘gaining momentum,’ says Jefferies
6M ago
VIGL
Vigil Neuroscience Advances Alzheimer’s Trial, Eyes 2025 Data
PremiumCompany Announcements
Vigil Neuroscience Advances Alzheimer’s Trial, Eyes 2025 Data
6M ago
8K
VIGL
Vigil Neuroscience announces FDA removed partial clinical hold on VG-3927
PremiumThe Fly
Vigil Neuroscience announces FDA removed partial clinical hold on VG-3927
6M ago
VIGL
Vigil Neuroscience price target lowered to $16 from $17 at Guggenheim
PremiumThe Fly
Vigil Neuroscience price target lowered to $16 from $17 at Guggenheim
8M ago
VIGL
Vigil Neuroscience sees cash runway into 2026
PremiumThe FlyVigil Neuroscience sees cash runway into 2026
8M ago
VIGL
Vigil Neuroscience reports Q2 EPS (52c), consensus (55c)
Premium
The Fly
Vigil Neuroscience reports Q2 EPS (52c), consensus (55c)
8M ago
VIGL
Vigil Neuroscience publishes new data on CSF1R gene variants
Premium
The Fly
Vigil Neuroscience publishes new data on CSF1R gene variants
8M ago
VIGL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >